Last reviewed · How we verify
NCT03731819
Establishment of Abbreviated Pancreatobiliary MRI Protocol
NA trial testing Abbreviated PB MRI in Pancreas Cyst in 30 participants. Completed in 4 May 2022.
12 November 2019
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 5 November 2018 |
| Primary completion | 12 November 2019 |
| Estimated completion | 4 May 2022 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Abbreviated PB MRI
Conditions studied
- Pancreas Cyst — all drugs for Pancreas Cyst →
- Intraductal Papillary Mucinous Neoplasm — all drugs for Intraductal Papillary Mucinous Neoplasm →
Sponsor
Seoul National University Hospital
Who can join
18 and older, any sex, with Pancreas Cyst or Intraductal Papillary Mucinous Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to establish abbreviated PB MRI protocol for patients on regular imaging follow-up for pancreas cystic neoplasm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03731819
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Abbreviated PB MRI
Trials testing the same drug.
- NCT04592393 — Pancreas Cancer Surveillance Using an Abbreviated MRI · NA · active not recruiting
Other recruiting trials for Pancreas Cyst
Currently open trials in the same condition.
- NCT05714111 — Radiology Registry on Pancreatic Malignancies · recruiting
- NCT05155878 — Prognostic Factors in Periampullary Tumors and Cysts · recruiting
- NCT04970056 — Pancreatic Cancer Early Detection Consortium · recruiting
- NCT03536793 — Tumour Regulatory Molecules in Early Pancreatic Cancer Detection · recruiting
- NCT03855800 — Molecular Detection of Advanced Neoplasia in Pancreatic Cysts · NA · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03731819 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 5 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03731819.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing